Osamu Tasaki Selected Research

Osamu Tasaki Research Topics

7	Wounds and Injuries (Trauma) 09/2020 - 11/2011
5	Sepsis (Septicemia) 01/2021 - 01/2010
5	Critical Illness (Critically Ill) 01/2020 - 01/2013
5	Infections 01/2018 - 08/2008
4	Out-of-Hospital Cardiac Arrest 01/2015 - 01/2011
4	Heart Arrest (Cardiac Arrest) 01/2015 - 02/2007
3	Shock 01/2021 - 01/2011
3	Inflammation (Inflammations) 01/2021 - 06/2014
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2013 - 08/2004
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2020 - 05/2009
2	Burns 01/2018 - 12/2005
2	Hypothermia 04/2011 - 07/2003
1	Septic Shock (Toxic Shock Syndrome) 01/2021
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2021
1	Venous Thromboembolism 01/2019
1	Airway Obstruction (Choking) 09/2014
1	Foreign Bodies (Foreign Body) 09/2014
1	Ventricular Fibrillation 07/2014
1	Rupture 07/2014
1	Heart Diseases (Heart Disease) 01/2014
1	Poisoning 01/2014
1	Heat Stroke (Heatstroke) 01/2014
1	Stroke (Strokes) 01/2014
1	Pathologic Constriction (Stenosis) 11/2013
1	Edema (Dropsy) 01/2013
1	Traumatic Intracranial Hemorrhage 01/2013
1	Hematoma 01/2013
1	Bacteremia 07/2012
1	Thrombosis (Thrombus) 01/2011
1	Disseminated Intravascular Coagulation 01/2011
1	Left Ventricular Dysfunction 11/2009
1	Endotoxemia 11/2009
1	Necrotizing Fasciitis 07/2008
1	Mediastinitis 07/2008
1	Persistent Vegetative State (Vegetative State) 02/2007
1	Disease Progression 12/2005
1	Craniocerebral Trauma (Head Injury) 12/2005
1	Brain Injuries (Brain Injury) 08/2004
1	Smoke Inhalation Injury 03/2002
1	Pulmonary Edema 02/2002

3	AcidsIBA 01/2021 - 07/2012
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2004
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2011 - 08/2008
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
2	Heparin (Liquaemin)FDA LinkGeneric 09/2020 - 03/2002
2	XenonIBA 02/2007 - 12/2005
1	Messenger RNA (mRNA)IBA 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	neogeninIBA 01/2021
1	Hydroxyindoleacetic AcidIBA 01/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2020
1	Volatile Fatty AcidsIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	fibrin fragment D (D-dimer)IBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	PlacebosIBA 01/2018
1	BilirubinIBA 02/2016
1	CholesterolIBA 02/2016
1	LipidsIBA 07/2014
1	Interleukin-8 (Interleukin 8)IBA 06/2014
1	Indicators and Reagents (Reagents)IBA 06/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 06/2014
1	LigandsIBA 06/2014
1	ProcalcitoninIBA 06/2014
1	Amino Acids FDA Link 02/2014
1	Biological ProductsIBA 01/2014
1	Histones (Histone)IBA 01/2014
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	SteroidsIBA 11/2011
1	ThrombomodulinIBA 01/2011
1	AnticoagulantsIBA 01/2011
1	Dacarbazine (DIC)FDA LinkGeneric 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2010
1	2,5-dichloro-4-bromophenol (B 2)IBA 02/2007
1	ElementsIBA 12/2005
1	InterleukinsIBA 05/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2005
1	CytokinesIBA 08/2004
1	lisofyllineIBA 03/2002
1	Malondialdehyde (Propanedial)IBA 02/2002

6	Therapeutics 09/2020 - 07/2003
3	Resuscitation 07/2014 - 04/2011
2	Cardiopulmonary Resuscitation (CPR) 01/2015 - 01/2015
2	Critical Care (Surgical Intensive Care) 07/2014 - 09/2013
2	Induced Hypothermia 07/2014 - 04/2011
1	Ligation 01/2018
1	Punctures 01/2018
1	Surgical Instruments (Clip) 09/2014
1	Extracorporeal Membrane Oxygenation 07/2014
1	Percutaneous Coronary Intervention 07/2014
1	Carotid Endarterectomy 11/2013
1	Patient Admission (Patient Admissions) 11/2011
1	Defibrillators (Defibrillator) 01/2011
1	Continuous Renal Replacement Therapy 11/2009
1	Hemofiltration 11/2009
1	Catheters 07/2008
1	Aftercare (After-Treatment) 07/2003